Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Zenith Drugs Ltd.

NSE: ZENITHDRUG | BSE:

₹132.95 1.80 (1.37%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

125.00

Today’s High

138.50

52W low

52.80

52W High

147.50

Open Price

131.20

Prev. Close

106.1500

Volume

158400.00

Value

21059280.00

Fundamentals

Market Cap

228.00

Price to Earnings

0.00

Price to Book Value

3.70

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

-13.01

Return on Equity %

15.40

EMA & SMA

Bullish Moving Averages

12

Bearish Moving Averages

1

5Day EMA

132.5

10Day EMA

127.6

12Day EMA

125.5

20Day EMA

117.8

26Day EMA

113.1

50Day EMA

100.4

100Day EMA

88.5

EMA

5Day SMA

134.7

10Day SMA

127.4

20Day SMA

116.3

30Day SMA

105

50Day SMA

95.4

100Day SMA

80.1

SMA

SMA

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Sep, 2024

65.7

Week

57.8

Month

65.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

132.13

PIVOT

First Resistance

139.32

Second Resistance

145.68

Third Resistance

152.87

First Support

125.77

Second Support

118.58

Third Support

112.22

Relative Strength Index

67.59

Money Flow Index

66.57

MACD

12.41

MACD Signal

11.13

Average True Range

9.06

Average Directional Index

45.94

Rate of Change (21)

64.14

Rate of Change (125)

99.33

Day Commodity Channel Index

83.5

Day Williams %R

-32.7

BETA

1 Month

3.1

3 Month

1.62

1 Year

3 Year

PRICE CHANGE ANALYSIS

↑ 3.83%

1 Week

Low

High

124.95

147.5

↑ 58.56%

1 Month

Low

High

78.3

147.5

↑ 109.7%

3 Months

Low

High

62

147.5

↑ 99.33%

6 Months

Low

High

52.8

147.5

↑ 68.29%

1 Year

Low

High

52.8

147.5

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 133.74 115.76 92.60 73.52 78.33
Operating Expenses Annual Cr 114.70 105.47 84.73 66.20 71.23
Operating Profit Annual 16.92 9.05 6.92 7.20 7.05
Operating Profit Margin Annual % 12.65 7.82 7.48 9.79 8.99
Total Expenses Annual Cr 119.00 109.10 88.20 68.92 73.46
EBIDT Annual Cr 19.04 10.29 7.87 7.31 7.11
EBIDT Annual margin % 14.24 8.89 8.50 9.95 9.07
Depreciation 1.30 1.30 1.34 1.22 0.92
PAT Before ExtraOrdinary Items Annual Cr 9.54 4.88 3.21 3.07 3.40
Net Profit Annual 9.54 4.88 3.21 3.07 3.40
Basic EPS Annual 122.03 5.56 80.32 76.66 85.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 62.22 17.73 12.85 9.64 6.57
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 7.85 7.84 7.81 7.55 9.73
Total Current Liabilities Annual Cr 64.10 71.65 45.53 29.35 27.42
Total Capital Plus Liabilities Annual Cr 134.17 97.22 66.18 46.54 43.72
Fixed Assets Annual 14.85 10.82 10.45 9.21 9.01
Total Non Current Assets Annual 21.34 13.14 12.40 10.69 9.01
Total Current Assets Annual 112.84 84.08 53.79 35.85 34.72
Total Assets Annual 134.17 97.22 66.18 46.54 43.72
Contingent Liabilities plus Commitments Annual Cr - - 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 0.00 0.00 4.91 -0.89 3.48
Cash from Investing Activity Annual 0.00 0.00 2.61 -1.43 -4.93
Cash from Financing Annual Activity 0.00 0.00 -0.83 2.88 1.36
Net Cash Flow Annual - - 6.69 0.57 -0.09
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 36.28 443.30 321.27 240.95 164.29
ROE Annual % 15.32 27.52 25.00 31.81 51.73
ROCE Annual % 25.31 35.13 31.63 35.43 37.96
Total Debt to Total Equity Annual 0.38 1.43 1.31 1.61 1.84
EBDIT Annual Margin % 14.46 8.98 8.58 9.96 9.08
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 133.74 115.70 92.67 73.52
Operating Expenses Annual Cr 114.70 104.85 84.82 66.37
Operating Profit Annual 16.92 9.67 6.83 7.03
Operating Profit Margin Annual % 12.65 8.36 7.37 9.56
Total Expenses Annual Cr 119.00 108.49 88.26 68.91
EBIDT Annual Cr 19.04 10.85 7.84 7.14
EBIDT Annual margin % 14.23 9.38 8.46 9.72
Depreciation 1.30 1.30 1.33 1.22
PAT Before ExtraOrdinary Items Annual Cr 9.65 5.15 3.13 3.03
Net Profit Annual 9.59 5.15 3.14 3.03
Basic EPS Annual 6.91 128.82 78.22 75.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 62.26 17.24 12.09 8.95
Minority Interest Liability Annual Cr 0.07 0.01 0.01 0.00
Total Non Current Liabilities Annual Cr 8.56 8.86 9.90 7.62
Total Current Liabilities Annual Cr 64.15 71.82 46.58 29.97
Total Capital Plus Liabilities Annual Cr 135.04 97.94 68.58 46.55
Fixed Assets Annual 15.25 11.73 13.13 9.22
Total Non Current Assets Annual 21.71 14.02 15.05 10.70
Total Current Assets Annual 113.33 83.92 53.53 35.85
Total Assets Annual 135.04 97.94 68.58 46.55
Contingent Liabilities plus Commitments Annual Cr - 0.25 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual -13.01 -4.41 5.15 0.76
Cash from Investing Activity Annual 26.00 0.11 -5.24 -1.43
Cash from Financing Annual Activity -4.47 4.91 1.24 2.08
Net Cash Flow Annual 8.52 0.61 1.15 1.41
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 36.35 431.47 302.64 223.82
ROE Annual % 15.40 29.88 25.95 33.83
ROCE Annual % 25.01 36.54 29.60 35.75
Total Debt to Total Equity Annual 0.40 1.51 1.56 1.73
EBDIT Annual Margin % 14.46 9.47 8.55 9.73
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
AJAY SINGH DASSUNDI 22.52 75290256 0 100
SANDEEP BHARDWAJ 21.38 75290257 0 100
BHUPESH SONI 20.18 75290260 0 100
JAYWANTI SONI 2.94 75290262 0 100
PRIYANKA BHARADWAJ 1.94 75290259 0 100
ANJALI DASSUNDI 0.8 75290258 0 100
Name Holding Percent Holding Id
MERU INVESTMENT FUND PCC-CELL 1 2.2 75290268
ARIES OPPORTUNITIES FUND LIMITED 1.47 75290267
VIKASA INDIA EIF I FUND - ZODIAC GLOBAL OPPORTUNITY FUND 1.23 75290269
NEOMILE GROWTH FUND - SERIES I 1.11 75290265
Name Holding Percent Holding Id
PRAVEEN MUDUNURI 1.11 75290273
GRETEX SHARE BROKING LIMITED 3.47 75290276
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED 1.17 75290277
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 29, 2024 Audited Results -
Ex-Date Bonus Ratio Record Date

FAQs

The latest market price of Zenith Drugs Ltd. on NSE was Rs. 132.95 as of today.

The opening share price of Zenith Drugs Ltd. was Rs. 131.20 as of today.

The 52-week high share price of Zenith Drugs Ltd. was Rs. 147.50.

The 52 week low share price of Zenith Drugs Ltd. was Rs. 52.80.

Please find Corporate actions section for more details.

The PE ratio of Zenith Drugs Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Zenith Drugs Ltd..

Close

Let's Open Free Demat Account